<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01196000</url>
  </required_header>
  <id_info>
    <org_study_id>07158</org_study_id>
    <secondary_id>NCI-2010-01427</secondary_id>
    <nct_id>NCT01196000</nct_id>
  </id_info>
  <brief_title>Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery</brief_title>
  <official_title>Laparoscopic Versus Robotic-Assisted Surgery for Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>City of Hope Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>City of Hope Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Robotic-assisted laparoscopic surgery may be a less invasive type of surgery for&#xD;
      rectal cancer and may have fewer side effects and improve recovery. It is not yet known&#xD;
      whether robotic-assisted laparoscopic surgery is more effective than laparoscopic surgery in&#xD;
      treating patients with rectal cancer.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial studies robotic-assisted laparoscopic surgery to see&#xD;
      how well it works compared to laparoscopic surgery in treating patients with rectal cancer&#xD;
      that can be removed by surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      I. To evaluate robotic-assisted rectal cancer surgery versus standard laparoscopic rectal&#xD;
      cancer resection by means of a randomized, controlled trial.&#xD;
&#xD;
      II. To assess technical ease of the operation, as determined by the clinical indicator of low&#xD;
      conversion rate to open operation.&#xD;
&#xD;
      III. To assess surgical accuracy and improved oncological outcome as determined by clear&#xD;
      pathological resection margins.&#xD;
&#xD;
      IV. To assess quality of life and analyze cost-effectiveness to aid evidence-based knowledge&#xD;
      to inform NHS and other service providers and decision-makers.&#xD;
&#xD;
      V. To analyze disease-free and overall survival and local recurrence rates at 3-year&#xD;
      follow-up.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients are randomized to 1 of 2 treatment arms.&#xD;
&#xD;
      ARM I: Patients undergo standard laparoscopic resection.&#xD;
&#xD;
      ARM II: Patients undergo robotic-assisted laparoscopic resection.&#xD;
&#xD;
      After completion of study treatment, patients are followed up at 1 month, 6 months, and then&#xD;
      annually thereafter for 3 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study has never been opened to accrual at COH. Study to be closed at COH due to the lack of&#xD;
    qualified robotic colorectal surgeons.&#xD;
  </why_stopped>
  <start_date>December 2011</start_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of conversion to open surgery as an indicator of surgical technical difficulty</measure>
    <time_frame>At completion of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Circumferential resection margin positivity rate</measure>
    <time_frame>At completion of pathology review</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local recurrence rate</measure>
    <time_frame>At 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative and post-operative complications</measure>
    <time_frame>At day 30 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative mortality</measure>
    <time_frame>At day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self reported bladder and sexual function</measure>
    <time_frame>At day 30 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>At day 30 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free and overall survival</measure>
    <time_frame>At 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative laparoscopic skills (randomly selected cases only) as assessed by the global assessment tool for evaluation of intra-operative laparoscopic skills (GOALS)</measure>
    <time_frame>Upon completion of GOALS assessment by an independent expert</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of the plane of surgery as assessed by central review of photographs</measure>
    <time_frame>At completion of the central review of photographs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economics</measure>
    <time_frame>At day 30 and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Recurrent Rectal Cancer</condition>
  <condition>Stage I Rectal Cancer</condition>
  <condition>Stage II Rectal Cancer</condition>
  <condition>Stage III Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergo standard conventional laparoscopic resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo robotic-assisted laparoscopic resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional laparoscopic surgery</intervention_name>
    <description>operation using conventional laparoscopic techniques</description>
    <arm_group_label>Arm I</arm_group_label>
    <other_name>laparoscopy-assisted surgery</other_name>
    <other_name>surgery, laparoscopic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>robotic-assisted laparoscopic surgery</intervention_name>
    <description>operation that involves use of laparoscopic assistance with robotic assistance</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_label>Arm II</arm_group_label>
    <other_name>quality of life assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion&#xD;
&#xD;
          -  Able to provide written informed consent&#xD;
&#xD;
          -  Diagnosis of rectal cancer amenable to curative surgery either by anterior resection&#xD;
             or abdominoperineal resection (i.e. staged T1-3, N0-2, M0 by CT and MRI or transrectal&#xD;
             ultrasound)&#xD;
&#xD;
          -  Rectal cancer suitable for resection by either standard or robotic-assisted&#xD;
             laparoscopic procedure&#xD;
&#xD;
          -  Fit for robotic-assisted or standard laparoscopic rectal resection&#xD;
&#xD;
          -  ASA =&lt; 3&#xD;
&#xD;
          -  Capable of completing required questionnaires at time of consent&#xD;
&#xD;
        Exclusion&#xD;
&#xD;
          -  Benign lesions of the rectum&#xD;
&#xD;
          -  Cancers of the anal canal&#xD;
&#xD;
          -  Locally advanced cancers not amenable to curative surgery&#xD;
&#xD;
          -  Locally advanced cancers requiring en bloc multi-visceral resection&#xD;
&#xD;
          -  Synchronous colorectal tumours requiring multi-segment surgical resection&#xD;
&#xD;
          -  Co-existent inflammatory bowel disease&#xD;
&#xD;
          -  Clinical or radiological evidence of metastatic spread&#xD;
&#xD;
          -  Concurrent or previous diagnosis of invasive cancer within 5 years that could confuse&#xD;
             diagnosis (non-melanomatous skin cancer or superficial bladder cancer treated with&#xD;
             curative intent are acceptable; for other cases please discuss with Chief Investigator&#xD;
             via CTRU)&#xD;
&#xD;
          -  History of psychiatric or addictive disorder or other medical condition that, in the&#xD;
             opinion of the investigator, would preclude the patient from meeting the trial&#xD;
             requirements&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Participation in another rectal cancer clinical trial relating to surgical technique&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessio Pigazzi</last_name>
    <role>Principal Investigator</role>
    <affiliation>City of Hope Medical Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>April 2012</verification_date>
  <study_first_submitted>September 3, 2010</study_first_submitted>
  <study_first_submitted_qc>September 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2010</study_first_posted>
  <last_update_submitted>April 16, 2012</last_update_submitted>
  <last_update_submitted_qc>April 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

